CEACAM5 and colon carcinoma: First, we examined mAb CC4′s activity of inducing antibody-dependent cell cytotoxicity (ADCC), since it was reported that anti-CEA mAb hMN-14 (labetuzumab) inhibited colonic carcinoma growth mainly by raising ADCC reaction [19].